Patients | Number of death | Overall mortality N = 95 | Melanoma-specific mortality N = 79 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | % | N | HR1) | (95% CI)2) | HR3) | (95% CI) | HR1) | (95% CI) | HR3) | (95% CI) | |
Gender | |||||||||||
Men | 216 | 47.1 | 60 | 1.0 | 1.0 7) | 1.0 | 1.0 7) | ||||
Women | 243 | 52.9 | 35 | 0.6 | (0.4 - 0.9) | 0.7 | (0.4 - 1.0) | 0.6 | (0.4-1.0) | 0.7 | (0.4 - 1.1) |
Largest basal tumour diameter (mm) | |||||||||||
≤ 10 | 168 | 36.6 | 21 | 1.0 | 1.0 8) | 1.0 | 1.0 8) | ||||
> 10 - ≤15 | 197 | 42.9 | 34 | 1.4 | (0.8 - 2.5) | 1.3 | (0.8 - 2.3) | 2.2 | (1.1 - 4.3) | 2.0 | (1.0 - 4.0) |
> 15 | 79 | 17.2 | 38 | 5.1 | (3.0 - 8.8) | 4.2 | (2.4 - 7.4) | 8.4 | (4.2 – 16.1) | 7.0 | (3.5 - 13.9 ) |
Extra ocular growth | |||||||||||
No | 451 | 98.3 | 1.0 | 1.0 8) | 1.0 | 1.0 8) | |||||
Yes | 7 | 1.5 | 2 | 1.7 | (0.4 - 7.0) | 1.2 | (0.3 - 4.8) | 2.0 | (0.5 - 8.2) | 1.2 | (0.3 - 4.8) |
Ciliary body involvement | |||||||||||
No | 368 | 80.2 | 60 | 1.0 | 1.0 9) | 1.0 | 1.0 9) | ||||
Yes | 87 | 19.0 | 34 | 2.7 | (1.8 - 4.2) | 1.8 | ( 1.1 - 2.8) | 3.0 | (1.9 - 4.7) | 1.7 | (1.0 - 2.8) |
Iris colour | |||||||||||
Dark4) | 62 | 13.5 | 7 | 1.0 | 1.0 7) | 1.0 | 1.0 7) | ||||
Light5) | 397 | 86.5 | 88 | 2.1 | (1.0 - 4.5) | 2.0 | (0.9 - 4.3) | 2.4 | (1.0-6.0) | 2.3 | (0.9 - 5.8) |
Children 6) | |||||||||||
No | 28 | 13.0 | 7 | 1.0 | 1.0 10) | 1.0 | 1.0 10) | ||||
Yes | 188 | 87.0 | 28 | 0.5 | (0.2 - 1.2) | 0.4 | (0.2 - 1.0) | 0.7 | (0.3 - 1.7) | 0.6 | (0.2 - 1.7) |
Number of children | |||||||||||
0 | 28 | 12.9 | 7 | 1.0 | 1.0 8) | 1.0 | 1.0 8) | ||||
1 | 62 | 28.7 | 10 | 0.6 | (0.2 - 1.6) | 0.5 | (0.2 - 1.4) | 0.8 | (0.3 - 2.3) | 0.7 | (0.2 - 2.3) |
2 | 87 | 40.3 | 12 | 0.5 | (0.2 - 1.3) | 0.4 | (0.2 - 1.1) | 0.5 | (0.2 - 1.6) | 0.5 | (0.2 - 1.5) |
≥3 | 39 | 18.1 | 6 | 0.6 | (0.2 - 1.6) | 0.4 | (0.1 - 1.3) | 0.8 | (0.2 - 2.5) | 0.7 | (0.2 - 2.5) |